IBB241122C158000
- 0.00
- 0.000.00%
iShares Biotechnology ETF Newsroom
Optimism Over Global Healthcare Sector Rises: Jefferies
Watching Shares Of Vaccine Stocks; Traders Circulate Article Titled "Top FDA Vaccine Official Says RFK Jr. Nomination Is a Chance for Scientist to Make the Case for Vaccines"
Sector Update: Health Care Stocks Rise Pre-Bell Thursday
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday as Snowflake Stimulates Lagging Market
Gilead Sciences Analyst Ratings
Biogen Analyst Ratings
Following the US Secretary of Health, Trump's nomination for the FDA Commissioner seems to be another anti-vaccine advocate.
Makari is a surgeon who opposes overtreatment, advocates for re-evaluating hormone replacement therapy, and reducing the overuse of antibiotics.
(IQV) - Analyzing IQVIA Hldgs's Short Interest
CDC Warns Against a Spike in COVID, Flu Cases
Decoding Amgen's Options Activity: What's the Big Picture?
Biogen Gains Momentum With Positive Lupus Drug Results, Analyst Sees Modest Valuation Upside
U.S. CDC Says Flu, Covid-19, RSV Illnesses Are At Low Levels Right Now Overall In U.S., But We Expect Them To Increase In Coming Weeks; Expects Hospitalizations For Flu And Covid-19 To Start Increasing In Coming Weeks
Argenx Analyst Ratings
Exchange-Traded Funds, Equity Futures Higher Pre-Bell as Traders Await Nvidia Earnings
US pharmaceutical stocks plummet, has the market overreacted to Little Kennedy?
Source: Analysis from Wall Street News states that even if Kennedy is confirmed as the Secretary of Health in the usa, he may not be able to "make a big impact". First, there may be divisions within Trump's team; secondly, it is uncertain whether Kennedy has the authority to appoint leaders of departments like the FDA; finally, Trump may appoint individuals with industry backgrounds as FDA commissioners, directing Kennedy's attention to focus on nutrition rather than pharmaceutical approvals. The famous "anti-vaccine pioneer" and advocate for healthy eating, the new government-nominated Secretary of Health Robert Kennedy, is dining with the loyal "fast food enthusiast" Trump, who promotes rapid vaccine development.
Silence Therapeutics' Zerlasiran Has Competitive Concerns: Analyst
High Alpha Stocks That Are Rated 'Overweight' – MS
BioNTech Started at Buy, Moderna at Hold by Berenberg
This BioNTech Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
Regeneron Pharmaceuticals's Options: A Look at What the Big Money Is Thinking